BAX and oral cavity squamous cell carcinoma: Recently, Li and colleagues described the in vivo effects of vicenin-2 (1; 30 mg kg−1), namely, the inhibition of Bcl-2 by triggering and/or activating apoptotic Bax in oral squamous cell carcinoma (OSCC) cell models [54].